| Product Code: ETC7917171 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Onchocerciasis Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Onchocerciasis Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Onchocerciasis Market - Industry Life Cycle |
3.4 Latvia Onchocerciasis Market - Porter's Five Forces |
3.5 Latvia Onchocerciasis Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.6 Latvia Onchocerciasis Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Latvia Onchocerciasis Market Revenues & Volume Share, By Drug, 2021 & 2031F |
3.8 Latvia Onchocerciasis Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Latvia Onchocerciasis Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.10 Latvia Onchocerciasis Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Latvia Onchocerciasis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about onchocerciasis in Latvia |
4.2.2 Growing investments in healthcare infrastructure |
4.2.3 Advancements in diagnostic technologies for onchocerciasis |
4.2.4 Government initiatives to control and eradicate onchocerciasis |
4.2.5 Rising prevalence of onchocerciasis in the region |
4.3 Market Restraints |
4.3.1 Limited availability of effective treatments for onchocerciasis |
4.3.2 High costs associated with treatment and management of onchocerciasis |
4.3.3 Lack of trained healthcare professionals specializing in onchocerciasis |
4.3.4 Challenges in reaching remote and rural areas for onchocerciasis control programs |
5 Latvia Onchocerciasis Market Trends |
6 Latvia Onchocerciasis Market, By Types |
6.1 Latvia Onchocerciasis Market, By Diagnosis |
6.1.1 Overview and Analysis |
6.1.2 Latvia Onchocerciasis Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.1.3 Latvia Onchocerciasis Market Revenues & Volume, By Physical Examination, 2021- 2031F |
6.1.4 Latvia Onchocerciasis Market Revenues & Volume, By Skin Biopsy, 2021- 2031F |
6.1.5 Latvia Onchocerciasis Market Revenues & Volume, By Mazzotti Test, 2021- 2031F |
6.1.6 Latvia Onchocerciasis Market Revenues & Volume, By Nodulectomy, 2021- 2031F |
6.1.7 Latvia Onchocerciasis Market Revenues & Volume, By PCR Test, 2021- 2031F |
6.1.8 Latvia Onchocerciasis Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Latvia Onchocerciasis Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Latvia Onchocerciasis Market Revenues & Volume, By Medication, 2021- 2031F |
6.2.3 Latvia Onchocerciasis Market Revenues & Volume, By Supportive Care, 2021- 2031F |
6.2.4 Latvia Onchocerciasis Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Latvia Onchocerciasis Market, By Drug |
6.3.1 Overview and Analysis |
6.3.2 Latvia Onchocerciasis Market Revenues & Volume, By Ivermectin, 2021- 2031F |
6.3.3 Latvia Onchocerciasis Market Revenues & Volume, By Moxidectin, 2021- 2031F |
6.3.4 Latvia Onchocerciasis Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Latvia Onchocerciasis Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Latvia Onchocerciasis Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Latvia Onchocerciasis Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Latvia Onchocerciasis Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Latvia Onchocerciasis Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Latvia Onchocerciasis Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 Latvia Onchocerciasis Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.5 Latvia Onchocerciasis Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Latvia Onchocerciasis Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Latvia Onchocerciasis Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Latvia Onchocerciasis Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.4 Latvia Onchocerciasis Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Latvia Onchocerciasis Market Import-Export Trade Statistics |
7.1 Latvia Onchocerciasis Market Export to Major Countries |
7.2 Latvia Onchocerciasis Market Imports from Major Countries |
8 Latvia Onchocerciasis Market Key Performance Indicators |
8.1 Number of onchocerciasis awareness campaigns conducted in Latvia |
8.2 Percentage increase in healthcare budget allocation towards onchocerciasis control |
8.3 Adoption rate of new diagnostic technologies for onchocerciasis screening |
8.4 Number of government policies implemented to combat onchocerciasis |
8.5 Trends in onchocerciasis prevalence rates in Latvia |
9 Latvia Onchocerciasis Market - Opportunity Assessment |
9.1 Latvia Onchocerciasis Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.2 Latvia Onchocerciasis Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Latvia Onchocerciasis Market Opportunity Assessment, By Drug, 2021 & 2031F |
9.4 Latvia Onchocerciasis Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Latvia Onchocerciasis Market Opportunity Assessment, By End User, 2021 & 2031F |
9.6 Latvia Onchocerciasis Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Latvia Onchocerciasis Market - Competitive Landscape |
10.1 Latvia Onchocerciasis Market Revenue Share, By Companies, 2024 |
10.2 Latvia Onchocerciasis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here